Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: a randomized clinical trial by Tian Wang, Xicai Sun, Hao Ding, Dehui Wang, Wanpeng Li, Haoyuan Xu, Quan Liu, Huankang Zhang, Yufei Yang, Huapeng Yu, Yurong Gu, Houyong Li

Get full text